X-Linked Adrenoleukodystrophy (X-ALD)
2 clinical trials · Condition
◉ Watch X-Linked Adrenoleukodystrophy (X-ALD)
| Record | Firm | Date |
|---|---|---|
| Long-term Follow-up of Participants With Cerebral Adrenoleukodystrophy Who Were Treated With Lenti-D Drug Product (NCT02698579) | Genetix Biotherapeutics Inc. | 2016-01-22 |
| Observational Study to Evaluate Allogeneic HSCT Outcomes for Cerebral Adrenoleukodystrophy (CALD) (NCT02204904) | Genetix Biotherapeutics Inc. | 2015-04-01 |
Track X-Linked Adrenoleukodystrophy (X-ALD) automatically
Every clearance here is in the API, with alerts when new ones post.